市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Vaxcyte, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.6
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.63 |
|
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 0.68% |
| 机构持股比例 | 117.40% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Janus Henderson Group Plc | 31 Dec 2025 | 13,387,188 |
| T. Rowe Price Investment Management, Inc. | 31 Dec 2025 | 11,296,333 |
| Paradigm Biocapital Advisors Lp | 31 Dec 2025 | 4,068,020 |
| Deep Track Capital, Lp | 31 Dec 2025 | 4,000,000 |
| Westfield Capital Management Co Lp | 31 Dec 2025 | 3,539,717 |
| Adage Capital Partners Gp, L.L.C. | 31 Dec 2025 | 1,725,000 |
| 52周波幅 | ||
| 中 | 116.00 (98.26%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Guggenheim | 02 Feb 2026 | 116.00 (98.26%) | 购买 | 57.40 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合